Trial Profile
A safety and efficacy trial of intravitreal bevacizumab (Avastin) with panretinal photocoagulation followed by ahmed valve implantation in the treatment of patient with neovascular glaucoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Glaucoma
- Focus Adverse reactions
- 03 Dec 2015 New trial record